Skip to content
No results
  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • 2026-05-01

Genmab A/S (NASDAQ:GMAB) To See Near-Term Downside Pressure Despite Active Buyback

Genmab enters the coming weeks with defensive technicals and mixed operating fundamentals while corporate actions supply episodic support. The current valuation as determined by WMDST classifies the stock as under-valued.
  • 2026-05-01

Onto Innovation Inc. (NYSE:ONTO) Leverages Cash-Rich Balance Sheet To Support Near-Term Momentum

Strong liquidity and recent product qualifications underpin a constructive near-term view, while margin compression and elevated valuation metrics warrant close monitoring.

  • 2026-05-01

PDF Solutions, Inc (NASDAQ:PDFS) Poised To Reaccelerate Revenue Growth Amid Improved Liquidity

PDF Solutions shows revenue momentum and enlarged liquidity that support continued operational scaling, while momentum indicators warn of a near-term consolidation. Fundamentals show a recovering margin profile and a WMDST-determined undervaluation.
  • 2026-05-01

KE Holdings Inc (NYSE:BEKE) Poised For Near-Term Bounce If Momentum Holds

KE Holdings shows mixed fundamental repair alongside short-term bullish technical momentum; valuation metrics and strong cash balances support upside potential over the coming weeks if momentum sustains.

  • 2026-05-01

First Merchants Corporation (NASDAQ:FRME) Positioned For Near-Term Integration-Driven Momentum

First Merchants enters a near-term phase defined by integration activity and mixed technical signals; fundamentals show earnings beat but elevated valuation ratios versus selective peer measures. Expect consolidation of recent deal gains to shape price action.
  • 2026-05-01

Hims & Hers Health, Inc (NYSE:HIMS) Accelerates Global Expansion While Navigating A Regulatory Reset

Hims & Hers enters an active growth phase backed by strategic acquisitions and new product pathways, even as regulatory and legal pressures reshape near-term commercialization of weight‑loss therapies.

  • 2026-04-30

Revolution Medicines, Inc (NASDAQ:RVMD) Sets Up For Near-Term Pullback Despite Strong Clinical Momentum

Revolution Medicines shows clinical breakthroughs that could alter its commercialization timeline, while short-term technicals and valuation metrics suggest heightened downside risk before any sustained advance.

  • 2026-04-30

Grindr, Inc (NYSE:GRND) Repositions Around Buyout Interest While Execution Risks Persist

Grindr shows mixed signals: strategic product moves and buyout chatter coexist with stretched valuation and uneven operational momentum. Near-term direction will depend on whether momentum indicators confirm follow-through or roll over.

  • 2026-04-30

YPF Sociedad Anonima (NYSE:YPF) Strengthens Liquidity And Credit Profile, Positioning For Near-Term Upside

YPF shows improved cash generation and clearer liability management while operational margins and commodity exposure shape a guardedly constructive near-term picture.
  • 2026-04-30

Newmont Corporation (NYSE:NEM) Navigates Near-Term Technical Weakness Despite Undervalued Fundamentals

Near-term technical signals point to pressure while company fundamentals and WMDST valuation indicate material intrinsic strength. The setup suggests consolidation with fundamental upside potential if momentum indicators turn constructive.
Prev
1 … 15 16 17 18 19 20 21 … 124
Next

GDS Holdings Limited (NASDAQ:GDS) Launches C‑REIT Move To Accelerate Liquidity

2025-09-05

Introducing The World’s Most Dangerous Swing Trader

2025-09-04
Prev
1 … 75 76 77 78

Trending now

Bill Holdings, Inc (NYSE:BILL) Executes Restructuring; Momentum Suggests Near-Term Stabilization
Silgan Holdings Inc. (NYSE:SLGN) Tightens Balance Sheet, Signals Near-Term Recovery Ahead
ACM Research, Inc (NASDAQ:ACMR) Poised For Short-Term Pullback Despite Continued Operational Momentum
Morgan Stanley (NYSE:MS) Shows Momentum But Valuation Signals Near-Term Pressure